Telemonitoring for TMD-Related Pain
Structured Telemonitoring as an Adjunct to Conservative Management of Temporomandibular Disorder-Related Orofacial Pain: A Randomized Clinical Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
This prospective randomized clinical trial evaluates the effectiveness of a structured telemonitoring protocol as an adjunct to conservative management in patients with temporomandibular disorder (TMD)-related orofacial pain. Participants receive standardized conservative therapy based on behavioural counselling, habit reversal training, and home-based self-management exercises, with or without structured telemonitoring. Clinical outcomes include pain intensity, mandibular function, and oral behaviours, assessed over a 9-month follow-up period. The study aims to determine whether telemonitoring improves treatment adherence, behavioural modification, and clinical outcomes compared with conventional in-office follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2026
CompletedFirst Submitted
Initial submission to the registry
August 10, 2026
CompletedFirst Posted
Study publicly available on registry
August 14, 2026
CompletedAugust 14, 2026
January 1, 2021
1.4 years
August 10, 2026
August 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Maximum pain-free mouth opening (mm)
Change in maximum pain-free mouth opening measured in millimetres (mm) as an indicator of mandibular functional improvement.
Baseline (T0), 3 months (T1), and 9 months (T2)
Mandibular lateral excursions (mm)
Change in right and left mandibular lateral excursion measured in millimetres (mm).
Baseline (T0), 3 months (T1), and 9 months (T2)
Protrusive movement (mm)
Change in maximum mandibular protrusive movement measured in millimetres (mm).
Baseline (T0), 3 months (T1), and 9 months (T2)
Pain intensity assessed using the Visual Analogue Scale (VAS)
Change in perceived pain intensity assessed using a 10-cm Visual Analogue Scale (VAS), where higher scores indicate greater pain intensity.
Baseline (T0), 3 months (T1), and 9 months (T2)
Secondary Outcomes (1)
Oral Behaviours Checklist (OBC) score
Baseline (T0), 3 months (T1), and 9 months (T2)
Study Arms (2)
Telemonitoring group (TG)
EXPERIMENTALThe TG received an active management protocol consisting of standard myofascial therapy combined with monthly in-office clinical evaluations and weekly structured remote interactions.
Control group (CG)
ACTIVE COMPARATORCG received conventional care based on monthly in-office clinical follow-up and standard therapeutic instructions without any form of remote monitoring.
Interventions
Weekly remote monitoring through text messaging and scheduled video consultations, in addition to standard conservative management.
Behavioural counselling, habit reversal training, and home-based self-management exercises with monthly in-office follow-up.
Eligibility Criteria
You may qualify if:
- Adults aged 18-80 years.
- Diagnosis of temporomandibular disorder (TMD) according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD).
- Presence of chronic orofacial pain persisting for more than 30 days.
- Diagnosis of myofascial pain involving the masticatory muscles, with or without headache attributed to TMD.
- Ability to use a mobile device compatible with telemonitoring procedures.
You may not qualify if:
- Systemic diseases affecting pain perception or neuromuscular function (including autoimmune, neurological, or neoplastic disorders).
- History of severe orofacial trauma.
- Previous major temporomandibular joint surgery.
- Ongoing orthodontic treatment.
- Current use of occlusal splints.
- Current use of muscle relaxants or psychoactive medications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Magna Graecia University of Catanzaro
Catanzaro, CZ, 88100, Italy
Related Publications (9)
Ben El Hammi N, Amessegher F, Moudni S, Jouhadi EM. Physiotherapy Approaches for Temporomandibular Disorders: A Multimodal Conservative Management Strategy. Cureus. 2025 Jul 28;17(7):e88885. doi: 10.7759/cureus.88885. eCollection 2025 Jul.
PMID: 40881526BACKGROUNDIodice G, Michelotti A, D'Anto V, Martina S, Valletta R, Rongo R. Prevalence of psychosocial findings and their correlation with TMD symptoms in an adult population sample. Prog Orthod. 2024 Oct 14;25(1):39. doi: 10.1186/s40510-024-00538-y.
PMID: 39397187BACKGROUNDOhrbach R, Michelotti A. The Role of Stress in the Etiology of Oral Parafunction and Myofascial Pain. Oral Maxillofac Surg Clin North Am. 2018 Aug;30(3):369-379. doi: 10.1016/j.coms.2018.04.011. Epub 2018 Jun 1.
PMID: 29866454BACKGROUNDSycinska-Dziarnowska M, Maglitto M, Wozniak K, Spagnuolo G. Oral Health and Teledentistry Interest during the COVID-19 Pandemic. J Clin Med. 2021 Aug 11;10(16):3532. doi: 10.3390/jcm10163532.
PMID: 34441828BACKGROUNDSaini RS, Chopra S, Assiri YA, Alhamoudi FH, Vaddamanu SK, Chaturvedi M, Kuruniyan MS, Banakar M, Heboyan A. Impact of mHealth and eHealth on oral health literacy: A systematic review. Digit Health. 2025 Jul 21;11:20552076251360955. doi: 10.1177/20552076251360955. eCollection 2025 Jan-Dec.
PMID: 40718406BACKGROUNDOhrbach R, Dworkin SF. The Evolution of TMD Diagnosis: Past, Present, Future. J Dent Res. 2016 Sep;95(10):1093-101. doi: 10.1177/0022034516653922. Epub 2016 Jun 16.
PMID: 27313164BACKGROUNDSchiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, List T, Svensson P, Gonzalez Y, Lobbezoo F, Michelotti A, Brooks SL, Ceusters W, Drangsholt M, Ettlin D, Gaul C, Goldberg LJ, Haythornthwaite JA, Hollender L, Jensen R, John MT, De Laat A, de Leeuw R, Maixner W, van der Meulen M, Murray GM, Nixdorf DR, Palla S, Petersson A, Pionchon P, Smith B, Visscher CM, Zakrzewska J, Dworkin SF; International RDC/TMD Consortium Network, International association for Dental Research; Orofacial Pain Special Interest Group, International Association for the Study of Pain. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Groupdagger. J Oral Facial Pain Headache. 2014 Winter;28(1):6-27. doi: 10.11607/jop.1151.
PMID: 24482784BACKGROUNDPeck CC, Goulet JP, Lobbezoo F, Schiffman EL, Alstergren P, Anderson GC, de Leeuw R, Jensen R, Michelotti A, Ohrbach R, Petersson A, List T. Expanding the taxonomy of the diagnostic criteria for temporomandibular disorders. J Oral Rehabil. 2014 Jan;41(1):2-23. doi: 10.1111/joor.12132.
PMID: 24443898BACKGROUNDManfredini D, Lombardo L, Siciliani G. Temporomandibular disorders and dental occlusion. A systematic review of association studies: end of an era? J Oral Rehabil. 2017 Nov;44(11):908-923. doi: 10.1111/joor.12531. Epub 2017 Jul 2.
PMID: 28600812BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
SELENE BARONE, PhDs, DDS
Magna Graecia University of Catanzaro
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 10, 2026
First Posted
August 14, 2026
Study Start
January 1, 2025
Primary Completion
June 1, 2026
Study Completion
July 15, 2026
Last Updated
August 14, 2026
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share